cytidine monophosphate has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkie, TN; DeWitte-Orr, SJ; Jenik, K; Kobasa, D; Semple, SL; Tailor, N; Warner, BM | 1 |
1 other study(ies) available for cytidine monophosphate and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro.
Topics: Angiotensin-Converting Enzyme 2; Antiviral Agents; Coronavirus 229E, Human; Coronavirus NL63, Human; COVID-19; Cytidine Monophosphate; Humans; Interferon Type I; Middle East Respiratory Syndrome Coronavirus; Nanoparticles; RNA; SARS-CoV-2 | 2022 |